drugset / Trial / NCT04738955
Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center, prospective, open, observational and optimal clinical research to evaluate the clinical effectiveness and safety of different doses of micafungin sodium for injection in patients with hematological tumors.
Timeline
- Start
- 2021-02-01
- Primary completion
- 2023-01-01
- Completion
- 2023-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Micafungin | Peptide | 100 mg | Intravenous |
| Subject | Micafungin | Peptide | 200 mg | Intravenous |
| Subject | Micafungin | Peptide | 300 mg | Intravenous |